2016. Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor. Colombia Medica. 47, 4 (Dec. 2016), 196–202. DOI:https://doi.org/10.25100/cm.v47i4.1989.